The prosocial compound ± 3,4-methylenedioxymethamphetamine (MDMA) is an amphetamine derivative that has shown promise as an adjunct to psychotherapy in the treatment of post-traumatic stress disorder. MDMA increases positive responses to social images, and it has been suggested that the ability of MDMA to positively bias social perception may underlie its therapeutic efficacy as a psychotherapy adjunct. However, the effect of the compound on affective responses to positive or negative social feedback has not been tested.
Aims:
In this study, we aimed to test the effects of MDMA compared to placebo and the prototypical stimulant, methamphetamine (MA), on responses to positive and negative social feedback.
Methods:
This was a double-blind, placebo-controlled, crossover trial (NCT03790618), comparing the effects of two doses of MDMA (0.75 mg/kg, 1.5 mg/kg) to both placebo and MA (20 mg) on responses to a personalized social feedback task, similar to a dating app, in healthy adult volunteers ages 18–40 (N = 36, 18 women, 18 men).
Results/Outcomes:
The high dose of MDMA increased positive affective responses to social feedback.
Conclusions/Interpretations:
These findings suggest one process by which MDMA may facilitate social connection. Further work is needed to understand how MDMA affects responses to more generalized types of social feedback and to understand these effects in clinical populations.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Arlington, VA: American Psychiatric Association.
2.
AgurtoCCecchiGANorelR, et al (2020) Detection of acute 3, 4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing. Neuropsychopharmacology45: 823–832.
3.
BaggottMJCoyleJRSiegristJD, et al (2016) Effects of 3, 4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. J Psychopharmacol30: 378–387.
4.
BaggottMJKirkpatrickMGBediG, et al (2015) Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol29: 669–677.
5.
BarkusEBadcockJC (2019) A transdiagnostic perspective on social anhedonia. Front Psychiatry10: 216.
6.
BediGCecchiGASlezakDF, et al (2014) A window into the intoxicated mind? Speech as an index of psychoactive drug effects. Neuropsychopharmacology39: 2340–2348.
7.
BediGPhanKLAngstadtM, et al (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology207: 73–83.
8.
BershadAKMayoLMVan HedgerK, et al (2019) Effects of MDMA on attention to positive social cues and pleasantness of affective touch. Neuropsychopharmacology44: 1698–1705.
9.
BershadAKMillerMABaggottMJ, et al (2016) The effects of MDMA on socio-emotional processing: does MDMA differ from other stimulants?J Psychopharmacol30: 1248–1258.
10.
DanforthALGrobCSStrubleC, et al (2018) Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacol235: 3137–3148.
11.
DelmonteSBalstersJMcGrathJ, et al (2012) Social and monetary reward processing in autism spectrum disorders. Mol Autism3: 7.
12.
DolderPCStrajharPVizeliP, et al (2018) Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects. Psychopharmacology235: 1389–1402.
13.
FryeCGWardleMCNormanGJ, et al (2014) MDMA decreases the effects of simulated social rejection. Pharmacol Biochem Behav117: 1–6.
14.
FulfordDCampelloneTGardDE (2018) Social motivation in schizophrenia: How research on basic reward processes informs and limits our understanding. Clin Psychol Rev63: 12–24.
15.
GabayASKemptonMJGilleenJ, et al (2019) MDMA increases cooperation and recruitment of social brain areas when playing trustworthy players in an iterated Prisoner’s dilemma. J Neurosci39: 307–320.
16.
GriffithsRRStitzerMCorkerK, et al (1977) Drug-produced changes in human social behavior: facilitation by d-amphetamine. Pharmacol Biochem Behav7: 365–372.
17.
HillKRHsuDTTaylorSF, et al (2022) Rejection sensitivity and mu opioid receptor dynamics associated with mood alterations in response to social feedback. Psychiatry Res Neuroimaging324: 111505.
18.
Holt-LunstadJSmithTBBakerM, et al (2015) Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci10: 227–237.
19.
HsuDTSanfordBJMeyersKK, et al (2015) It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol Psychiatry20: 193–200.
20.
HsuDTSanfordBJMeyersKK, et al (2013) Response of the μ-opioid system to social rejection and acceptance. Mol Psychiatry18: 1211–1217.
21.
HsuDTSankarAMalikMA, et al (2020) Common neural responses to romantic rejection and acceptance in healthy adults. Soc Neurosci15: 571–583.
22.
HysekCMDomesGLiechtiME (2012) MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions. Psychopharmacology222: 293–302.
23.
HysekCMSchmidYSimmlerLD, et al (2014) MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci9: 1645–1652.
24.
Kamilar-BrittPBediG (2015) The prosocial effects of 3, 4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals. Neurosci Biobehav Rev57: 433–446.
25.
KennedyDPAdolphsR (2012) The social brain in psychiatric and neurological disorders. Trends Cogn Sci16: 559–572.
26.
KirkpatrickMDeltonAWRobertsonTE, et al (2015) Prosocial effects of MDMA: a measure of generosity. J Psychopharmacol29: 661–668.
27.
KirkpatrickMGLeeRWardleMC, et al (2014) Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology39: 1654–1663.
28.
KupferbergABicksLHaslerG (2016) Social functioning in major depressive disorder. Neurosci Biobehav Rev69: 313–332.
29.
KuypersKPde la TorreRFarreM, et al (2014) No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation. PLoS One9: e100719.
30.
KuypersKPDolderPCRamaekersJG, et al (2017) Multifaceted empathy of healthy volunteers after single doses of MDMA: a pooled sample of placebo-controlled studies. J Psychopharmacol31: 589–598.
31.
LiechtiME (2015) Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling. Swiss Med Wkly145: w14043.
32.
MarroneGFPardoJSKraussRM, et al (2010) Amphetamine analogs methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA) differentially affect speech. Psychopharmacology208: 169–177.
33.
MitchellJMBogenschutzMLiliensteinA, et al (2021) MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med27: 1025–1033.
NawijnLvan ZuidenMFrijlingJL, et al (2015) Reward functioning in PTSD: a systematic review exploring the mechanisms underlying anhedonia. Neurosci Biobehav Rev51: 189–204.
36.
O"MathúnaBFarréMRostami-HodjeganA, et al (2008) The consequences of 3, 4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans. J Clin Psychopharmacol28: 523–529.
37.
RothmanRBBaumannMHDerschCM, et al (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse39: 32–41.
38.
RudnickGWallSC (1992) The molecular mechanism of" ecstasy"[3, 4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci U S A89: 1817–1821.
39.
SankarAYttredahlAAFourcadeEW, et al (2019) Dissociable neural responses to monetary and social gain and loss in women with major depressive disorder. Front Behav Neurosci13: 149.
40.
SchmidYHysekCMSimmlerLD, et al (2014) Differential effects of MDMA and methylphenidate on social cognition. J Psychopharmacol28: 847–856.
41.
SherdellLWaughCEGotlibIH (2012) Anticipatory pleasure predicts motivation for reward in major depression. J Abnorm Psychol121(1): 51.
42.
SottileRJVidaT (2022) A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy. Front Psychiatry13: 991753.
43.
TancerMJohansonC-E (2003) Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug Alcohol Depend72: 33–44.
44.
ThompsonMCallaghanPDHuntGE, et al (2007) A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine (“ecstasy”). Neuroscience146: 509–514.
45.
van WelJHKuypersKPTheunissenEL, et al (2012) Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors. PLoS One7: e40187.
46.
VenturaJWoodRCJimenezAM, et al (2013) Neurocognition and symptoms identify links between facial recognition and emotion processing in schizophrenia: meta-analytic findings. Schizophr Res151: 78–84.
47.
VizeliPStraumannIDuthalerU, et al (2022) Effects of 3, 4-methylenedioxymethamphetamine on conditioned fear extinction and retention in a crossover study in healthy subjects. Front Pharmacol13: 906639.
48.
WardASKellyTHFoltinRW, et al (1997) Effects of d-amphetamine on task performance and social behavior of humans in a residential laboratory. Exp Clin Psychopharmacol5: 130.
49.
WardleMCde WitH (2014) MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology231: 4219–4229.
50.
WardleMCGarnerMJMunafòMR, et al (2012) Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior. Psychopharmacology223: 199–210.
51.
XieWYanCYing XyZS, et al (2014) Domainspecific hedonic deficits towards social affective but not monetary incentives in social anhedonia. Sci Rep4: 4056.
52.
YttredahlAAMcRobertEShelerB, et al (2018) Abnormal emotional and neural responses to romantic rejection and acceptance in depressed women. J Affect Disord234: 231–238.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
